Last edition
News about "NVIDIA "
Lilly Partners with NVIDIA to Build AI Supercomputer for Drug Discovery and Delivery
Eli Lilly has partnered with NVIDIA to build AI supercomputer, aimed at accelerating the discovery and delivery of new medicines. The collaboration will leverage advanced AI capabilities to identify, optimise, and validate novel molecules, with additional applications in manufacturing, medical imaging, and enterprise AI solutions.
NVIDIA | 31/10/2025 | By Dineshwori
Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform
Fischer Medical Ventures’ associate company, Nanyang Biologics (NYB), has entered into a strategic collaboration with global technology leaders NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build VECURA – an AI-powered drug discovery platform.
NVIDIA | 03/09/2025 | By Dineshwori | 183
NVIDIA Teams Up with Industry Leaders to Accelerate Genomics and Drug Discovery
Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.
NVIDIA | 15/01/2025 | By Aishwarya | 341
ConcertAI, NVIDIA to Transform Translational and Clinical Development Solutions
ConcertAI has joined hands with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform.
NVIDIA | 03/06/2024 | By Aishwarya | 479
Sartorius to Ramp Up Drug Discovery and Production with AI in Alliance with NVIDIA
Sartorius has extended its multidisciplinary partnership with NVIDIA to help enable the development of new and better therapies, combining Sartorius’ in-depth knowledge of life sciences and bioprocessing with NVIDIA’s AI-powered computing platforms and software.
NVIDIA | 17/05/2024 | By Aishwarya | 375
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy